Table 2.
Combination of probiotics and prebiotics used as therapeutics in clinical studies
Probiotics | Prebiotics | Applications | References |
---|---|---|---|
Arginolytic bacteria | Arginine | To prevent and manage dental caries; Improve oral health | Zaura and Twetman (2019) and Bijle et al. (2020a) |
Lactobacillus rhamnosus | L-arginine | Growth inhibition of pathogenic microbes i.e. S. mutans; Caries prevention | Bijle et al. (2020b) |
Lactobacilli spp. L. gasseri, L. paracasei, L. fermentum, Lb. plantarum |
Saccharides | Stimulated growth of beneficial probiotic microorganisms; Suppression of oral pathogens & improvement of mouth ecology; Affect cariogenic bacteria Streptococcus mutans | Nunpan et al. (2019) |
L. acidophilus DSMZ 20079 or ATCC 4356 |
3% fructooligosaccharides; 3% galactooligosaccharides and 1% fructooligosaccharides |
Reduced the growth rate of S. mutans | Nunpan et al. (2019) |
Lactobacillus & Bifidobacterium species | Fructo-oligosaccharides (FOS) | Eradication of Helicobacter pylori | Sirvan et al. (2017) |
Lactobacillus, Bacillus & Bifidobacterium species | GOS, FOS | Treatment of inflammation | Soleimani et al. (2019) |
Lactobacillus species | Inulin | Treatment of dyslipidaemia & Diabetes | Asemi et al. (2017) andTajabadi- Ebrahimi et al. (2017) |
Lactobacillus & Bifidobacterium species | Litesse Ultra polydextrose, FOS | Treatment of obesity and To treat metabolic syndrome (MS) and obesity associated problems | Hibberd et al. (2019) and Rabiei et al. (2019) |
Lactobacillus species | Fructo-oligosaccharides (FOS) | To prevent sepsis in infants | Panigrahi et al. (2017) |
L. bulgaricus and L. rhamnosus | XOS and RGE | Recoverey of intestinal microbiota | Li et al. (2020) |
Lactobacillus gasseri 505 | Cudraniatricuspidata leaf extract | Protection against colitis-related colorectal cancer | Oh et al. (2020) |
Enterococcus faecium | Agave inulin | Improvement in learning and memory | Romo-Araiza et al. (2018) |
L. bulgaricus and L. rhamnosus |
Xylooligosaccharide and red ginseng extracts |
Recovery of intestinal microbiota |
Li et al. (2020) |
Bifidobacterium longum UABl-14, Bifidobacterium lactis UABla-12, Bifidobacterium bifidum UABb-10, Lactobacillus acidophilus DDS-1 |
Trans-galactooligosaccharide (GOS) | Reduce obesity and associated symptoms | Sergeev et al. (2020) |